The results reported here indicate that both phosphorylation of eIF2α and levels of BRCA1 may provide needed biomarkers for future clinical studies assessing the potential effect of n-3 PUFAs on breast cancer risk and perhaps identifying individuals that may benefit from dietary intervention. This evidence concerns the gene EIF2A and breast cancer.